Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 11 (3) , 515-522
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nivolumab in Previously Untreated Melanoma withoutBRAFMutationNew England Journal of Medicine, 2015
- Aging, cancer, and cancer vaccinesImmunity & Ageing, 2012
- Immunosenescence and cancerJournal of Geriatric Oncology, 2010
- Cutaneous melanoma in the elderly: epidemiology, prognosis and treatmentMelanoma Research, 2010
- Immunosenescence and cancer vaccinesCancer Immunology, Immunotherapy, 2009
- Dying with cancerCancer, 2008
- Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II TrialsJournal of Clinical Oncology, 2008
- Reviewing the definition of “elderly”Geriatrics & Gerontology International, 2006
- AGING AND CANCER IN AMERICAHematology/Oncology Clinics of North America, 2000
- Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating ScalePsychiatry Research, 1992